UK markets open in 3 hours 50 minutes

NIKKEI 225
38,913.48
+296.38(+0.77%)
HANG SENG
18,902.56
-293.04(-1.53%)
CRUDE OIL
77.04
-0.53(-0.68%)
GOLD FUTURES
2,371.60
-21.30(-0.89%)
DOW
39,671.04
-201.95(-0.51%)
Bitcoin GBP
54,549.45
-426.00(-0.77%)

How to protect your finances during divorce

However you do it divorce will leave you poorer, and you will need to watch your finances carefully

BPMC Oct 2024 85.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

4.7000

-3.7000

(-44.05%)

As of 11:00AM EDT. Market open.

Simply Wall St.
Blueprint Medicines (NASDAQ:BPMC) pulls back 3.5% this week, but still delivers shareholders notable 85% return over 1 year
If you want to compound wealth in the stock market, you can do so by buying an index fund. But investors can boost...
Zacks
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand have been highlighted in this Industry Outlook article.
PR Newswire
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective May 1, 2024, the Compensation Committee of Blueprint Medicines' Board of Directors granted non-qualified stock options to purchase an aggregate of 6,400 shares of its common stock and an aggregate of 3,200 restricted stock units (RSUs) to two new employees under Blueprint Medicines' 2020 Inducement Plan.